eureKARE Overview
eureKARE is an investment company dedicated to advancing synthetic biology innovation throughout Europe. The firm believes in the transformative potential of synthetic biology to address global health and environmental challenges. By pioneering a novel startup creation and development model, eureKARE fosters a vibrant ecosystem of early and later-stage ventures through its network of biotech studios, acting as bridges between academia and industry to accelerate innovations into robust companies.
Is eureKARE the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with eureKARE, along with a list of other relevant VCs, is available on Hopohopo.io.
eureKARE
Investment focus
Invest in
- Baltics
- Nordics
- Western Europe
- Southern Europe
- Central Eastern Europe
- Middle East 1 / 16
Product type
- Drugs / Pharma
- Other
Industries / verticals
- BioTech & Life Sciences
Stages
Pre-seed, Seed, Series A
First ticket size
€3,000,000 - €10,000,000
How to approach funds like eureKARE
When engaging with eureKARE, founders should highlight how their synthetic biology solution bridges academic research and commercial application, demonstrating a clear path from scientific innovation to market impact. Emphasize your team's technical depth, translational potential, and readiness to leverage eureKARE's studio network for rapid development and scaling. Articulate how your venture fits into a broader ecosystem and can benefit from collaborative, cross-disciplinary support to accelerate from concept to company.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
